跳至主要内容
临床试验/CTRI/2017/01/007624
CTRI/2017/01/007624已完成3 期

Role of inhaled beta-2 agonist for the treatment of transient tachypnea of newborn

St Stephens Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Neonates more than 34 weeks diagnosed as transient tachypnea of newborn according to: - symptoms within first 6 hours after birth
  • - x-ray chest consistent with retained fetal lung fluid

排除标准

  • 1.premature infants less than 35 weeks
  • 2. Neonates with meconium aspiration syndrome or septecemia
  • 3.neonates with hyaline memberane disease
  • 4.neonates with birth asphyxia
  • 5. Neonates with congenital heart disease

研究者

发起方
St Stephens Hospital

相似试验

Role of a drug in neonates for the treatment of... | 临床试验